What is WellDoc?
WellDoc operates at the forefront of digital health, providing a comprehensive chronic care platform designed to integrate personalized, real-time, and actionable insights into the daily lives of patients. The company's technology supports multi-condition management, encompassing diabetes, hypertension, heart failure, and behavioral health, with the ultimate goal of improving patient outcomes and overall health. This strategic focus positions WellDoc as a key player in the evolving landscape of remote patient monitoring and personalized medicine.
How much funding has WellDoc raised?
WellDoc has raised a total of $56.3M across 6 funding rounds:
Private Equity
$1M
Private Equity
$8.4M
Series A
$20M
Private Equity
$4.5M
Series B
$22M
Debt
$350K
Private Equity (2006): $1M, investors not publicly disclosed
Private Equity (2012): $8.4M, investors not publicly disclosed
Series A (2014): $20M supported by Merck Global Health Innovation Fund, Windham Venture Partners, and TCP Venture Capital
Private Equity (2014): $4.5M, investors not publicly disclosed
Series B (2015): $22M backed by Adage Capital Management, Hudson River Capital Partners, Excel Venture Management, Samsung Ventures, and Alexandria Venture Investments
Debt (2020): $350K with participation from PPP
Key Investors in WellDoc
Adage Capital Management
Adage Capital Management is a money management firm primarily focused on S&P 500 assets, headquartered in Boston, Massachusetts.
Hudson River Capital Partners
Hudson River Capital Partners is a small-cap, private investment firm focused on healthcare businesses, both services and products, headquartered in Westchester County, NY.
Samsung Ventures
Samsung Ventures is a venture capital firm operating in the Venture Capital & Private Equity industry, headquartered in State College, Pennsylvania.
What's next for WellDoc?
The substantial enterprise-level funding and recent strategic investment indicate a strong market validation for WellDoc's approach to chronic disease management. This capital infusion is expected to fuel further platform development, expand market reach, and enhance strategic partnerships. The company is poised to scale its operations, leveraging technology to create a more connected and effective healthcare ecosystem for individuals with chronic conditions, potentially driving significant growth and impact in the digital therapeutics sector.
See full WellDoc company page
